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INTRODUCTION
Australia is contributing to the global problem of antimicrobial resistance  
with one of the highest rates of antibiotic use amongst OECD countries.1  
It is estimated that antimicrobial resistance costs Australians over $750 
million per year.2 Data from the Australian primary healthcare sector suggests 
unnecessary antibiotics were prescribed for conditions that will resolve 
without it.3 If left unchecked, this will result in more resistant  
micro-organisms, against which antibiotics will be useless. 
There is a lack of understanding about what is influencing decisions  
to use antibiotics – what factors influence general practitioners (GPs)  
to prescribe antibiotics, consumers to seek antibiotics, and pharmacists  
to fill old antibiotic prescriptions? It is also not clear how these  
individuals trade-off between the possible benefits that antibiotics  
may provide in the immediate/short term, against the longer term  
societal risk of antimicrobial resistance.
Method
This project will investigate (a) what factors 
drive decisions to use antibiotics for GPs, 
pharmacists and consumers, and (b) how  
these individuals discount the future.
Factors will be gleaned from published 
literature and from a qualitative phase using 
semi-structured interviews, to inform the 
development of Discrete Choice Experiments 
(DCEs). Three DCEs will be constructed – one for 
each group of interest – to allow investigation 
of which factors are more important in 
influencing (a) GPs to prescribe antibiotics, 
(b) consumers to seek antibiotics, and (c) 
pharmacists to fill legally valid but old or repeat 
prescriptions of antibiotics. Regression analysis 
will be conducted to understand the relative 
importance of these factors.
A Time Trade Off exercise will be developed 
to investigate how these individuals discount 
the future, and whether GPs and pharmacists 
display the same extent of discounting the 
future, as consumers. 
Expected Results
Findings from the DCEs will provide an insight 
into which factors are more important in driving 
decision making in antibiotic use for GPs, 
pharmacists and consumers. Findings from the 
Time Trade Off exercise will show what individuals 
are willing to trade for preserving the utility of 
antibiotics into the future.
Conclusion
The emergence of antibiotic resistance is 
inevitable. This research will expand on  
what is currently known about influencing 
desired behaviour change in antibiotic use  
in the fight against antibiotic resistance. 
Real World Implications
Research findings will contribute to existing national 
programs to bring about a reduction in inappropriate use of 
antibiotics in Australia. Specifically, influencing (1) how key 
messages and public health campaigns are crafted to increase 
health literacy, and (2) clinical education and empowerment 
of GPs and pharmacists to play a more responsive role as 
stewards of antibiotic use in the community. 
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INTERVIEWS
What influences antibiotic 
use for GPs, consumers and 
community pharmacists?
How do these individuals trade-
off on these factors?
How do these individuals 
discount the future?
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recommendations
•  National Public Health 
Campaigns
•  Clinical Education of GPs & 
community pharmacists
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